Literature DB >> 20831883

Concentrated epidemics of HIV, HCV, and HBV among Afghan refugees.

Muhammad Rafiq Khanani, Amna S Ansari, Saeed Khan, Mehreen Somani, Shahana Urooj Kazmi, Syed H Ali.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20831883     DOI： 10.1016/j.jinf.2010.08.009

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  12 in total

1.  Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.

Authors:  Ghina R Mumtaz; Helen A Weiss; Peter Vickerman; Natasha Larke; Laith J Abu-Raddad
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

Review 2.  Epidemiology of Substance Use among Forced Migrants: A Global Systematic Review.

Authors:  Danielle Horyniak; Jason S Melo; Risa M Farrell; Victoria D Ojeda; Steffanie A Strathdee
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 3.  Opium trade and the spread of HIV in the Golden Crescent.

Authors:  Syeda Ayesha Farooq; Mohammad Hafiz Rasooly; Syed Hani Abidi; Kayvon Modjarrad; Syed Ali
Journal:  Harm Reduct J       Date:  2017-07-21

Review 4.  Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.

Authors:  Shah Jahan Shayan; Rajab Nazari; Frank Kiwanuka
Journal:  Harm Reduct J       Date:  2021-05-27

5.  Burden of communicable disease among the native and repatriating Afghans.

Authors:  Syed H Abidi; Farwa Ali; Farida Shah; Farhat Abbas; Syed Ali
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

6.  Knowledge, attitudes and practices of contraception among Afghan refugee women in Pakistan: a cross-sectional study.

Authors:  Hina Raheel; Mehtab S Karim; Sarah Saleem; Sulaiman Bharwani
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

7.  Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV.

Authors:  Ambreen Khokhar; Samina Noorali; Muhammad Sheraz; Kuha Mahalingham; Donald G Pace; Mohammad R Khanani; Omar Bagasra
Journal:  Libyan J Med       Date:  2012-12-31       Impact factor: 1.657

8.  HIV-1 subtype A gag variability and epitope evolution.

Authors:  Syed Hani Abidi; Marcia L Kalish; Farhat Abbas; Sarah Rowland-Jones; Syed Ali
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

Review 9.  HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.

Authors:  Ghina R Mumtaz; Helen A Weiss; Sara L Thomas; Suzanne Riome; Hamidreza Setayesh; Gabriele Riedner; Iris Semini; Oussama Tawil; Francisca Ayodeji Akala; David Wilson; Laith J Abu-Raddad
Journal:  PLoS Med       Date:  2014-06-17       Impact factor: 11.069

10.  Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis.

Authors:  Gayathri S Kumar; Clelia Pezzi; Simone Wien; Blain Mamo; Kevin Scott; Colleen Payton; Kailey Urban; Stephen Hughes; Lori Kennedy; Nuny Cabanting; Jessica Montour; Melissa Titus; Jenny Aguirre; Breanna Kawasaki; Rebecca Ford; Emily S Jentes
Journal:  PLoS Med       Date:  2020-03-31       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.